Olympic silver medallist and World Champion, Roger Black MBE, supports Panthera’s clinical trials investigating potential new medicines for cardiovascular disease (CVD)
The former Olympic athlete visited Panthera’s clinical research clinic in Enfield in October Roger stresses the need for patients to take part in clinical trials to advance new medicines Roger…
Panthera becomes the world’s first clinical trial site to administer Valneva’s inactivated COVID-19 vaccine (VLA2001) to volunteers in phase 3 study
Panthera has started vaccinating volunteers in Valneva’s double-blind, phase three, COVID prevention trial. The trial will compare Valneva’s inactivated vaccine, VLA2001, with AstraZeneca’s conditionally approved vaccine Vaxzeria. Unlike earlier COVID-19…
Panthera further extends its network of clinical trial sites with the opening of a clinical trial site in North London in collaboration with Medicus Health Partners
Panthera’s network of UK clinical trials sites grows to seven with several others in development. Since launching its first site in Preston in North West England in 2019, Panthera continues…